Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.94
+0.58411.70%
Volume:867
Turnover:30.29K
Market Cap:97.13M
PE:- -
High:34.94
Open:34.94
Low:34.94
Close:34.36
52wk High:36.84
52wk Low:23.42
Shares:2.78M
Float Shares:2.78M
Volume Ratio:1.94
T/O Rate:0.03%
Dividend:0.26
Dividend Rate:0.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Shenyang Xingqi Pharma Gains NMPA Approval to Initiate Clinical Trials for SQ-25012 Injection in Thyroid Eye Disease

Stock News
·
Sep 15

港股市场动态:海西新药股价上扬,新药申请获受理推进

Stock News
·
Sep 15

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Stock News
·
Sep 15

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
Sep 15

CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates

Deep News
·
Sep 14

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Sep 14

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Sep 14

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Sep 14

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Sep 14

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Sep 14

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Sep 14

Market Consolidation with Low Volume: Innovative Drugs Surge Against the Trend, Banking Index Hits New Annual High, Optical Module Leaders Retreat While Capital Seeks Opportunities in High-Optical ETFs

Deep News
·
Sep 14

ETF Market Recap: Short-Term Opportunities Emerge in Previously Corrected Innovative Drug and CXO Sectors Amidst Soft Broader Market Momentum

Deep News
·
Sep 14

Hengrui's Novel Factor XI Monoclonal Antibody Wins NMPA Acceptance for VTE Prevention in Elective Knee Replacement Surgery

Deep News
·
Sep 14

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Stock News
·
Sep 14

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Sep 14

ETF Market Daily Review (09.14) | WCLC Clinical Data Delivers Strong Results, Innovative Drug Sector Rebounds Amid Shifting Computing Power Demand Outlook

Stock News
·
Sep 14